Quinpirole-induced 50kHz ultrasonic vocalization in the rat: Role of D2 and D3 dopamine receptors

Behavioural Brain Research

Volumn 226, Issue 2, 2012, Pages 511-518

  Brudzynski, Stefan M ^a   Komadoski, Melanie ^a   St Pierre, Joel ^a,b  

^a BROCK UNIVERSITY   (Canada)

^b Mohawk College of Applied Arts and Technology   (Canada)

Author keywords

50kHz calls; D2 D3 dopamine antagonists; Dopamine receptors; Quinpirole; Raclopride; Rat; U 99194A; Ultrasonic vocalization

Indexed keywords

2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; AMPHETAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; QUINPIROLE; RACLOPRIDE; SODIUM CHLORIDE; (5,6 DIMETHOXYINDAN 2 YL)DIPROPYLAMINE; (5,6-DIMETHOXYINDAN-2-YL)DIPROPYLAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; INDAN DERIVATIVE;

ACOUSTICS; ANIMAL EXPERIMENT; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG MEGADOSE; GLOBUS PALLIDUS; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN FUNCTION; PUTAMEN; RAT; SEPTUM NUCLEUS; VOCALIZATION; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; MICROINJECTION; PHYSIOLOGY; WISTAR RAT;

ANIMALS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INDANS; MALE; MICROINJECTIONS; NUCLEUS ACCUMBENS; QUINPIROLE; RACLOPRIDE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; VOCALIZATION, ANIMAL;

EID: 81355148435     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.10.004     Document Type: Article

References (54)

1. Brudzynski S.M. Vocalization as an ethotransmitter: introduction to the handbook of mammalian vocalization. Handbook of mammalian vocalization. An integrative neuroscience approach 2010, 3-9. Academic Press/Elsevier, Amsterdam. S.M. Brudzynski (Ed.).
2. Browning J.R., Browning D.A., Maxwell A.O., Dong Y., Jansen H.T., Panksepp J., et al. Positive affective vocalizations during cocaine and sucrose self-administration: a model for spontaneous drug desire in rats. Neuropharmacology 2011, 61(1-2):268-275.
3. Brudzynski S.M. Ultrasonic calls of rats as indicator variables of negative or positive states: acetylcholine-dopamine interaction and acoustic coding. Behav Brain Res 2007, 182(2):261-273.
4. Knutson B., Burgdorf J., Panksepp J. High-frequency ultrasonic vocalizations index conditioned pharmacological reward in rats. Physiol Behav 1999, 66(4):639-643.
5. Knutson B., Burgdorf J., Panksepp J. Ultrasonic vocalizations as indices of affective states in rats. Psychol Bull 2002, 128(6):961-977.
6. Burgdorf J., Kroes R.A., Moskal J.R., Pfaus J.G., Brudzynski S.M., Panksepp J. Ultrasonic vocalizations of rats (Rattus norvegicus) during mating, play, and aggression: behavioral concomitants, relationship to reward, and self-administration of playback. J Comp Psychol 2008, 122(4):357-367.
7. Panksepp J., Burgdorf J. 50-kHz chirping (laughter?) in response to conditioned and unconditioned tickle-induced reward in rats: effects of social housing and genetic variables. Behav Brain Res 2000, 115(1):25-38.
8. Burgdorf J., Moskal J.R. Frequency modulated 50kHz ultrasonic vocalizations reflect a positive emotional state in the rat: neural substrates and therapeutic implications. Handbook of mammalian vocalization. An integrative neuroscience approach 2010, 209-214. Academic Press/Elsevier, Amsterdam. S.M. Brudzynski (Ed.).
9. Biały M., Rydz M., Kaczmarek L. Precontact 50-kHz vocalizations in male rats during acquisition of sexual experience. Behav Neurosci 2000, 114(5):983-990.
10. Brudzynski S.M., Pniak A. Social contacts and production of 50-kHz short ultrasonic calls in adult rats. J Comp Psychol 2002, 116(1):73-82.
11. Burgdorf J., Panksepp J. Tickling induces reward in adolescent rats. Physiol Behav 2001, 72(1-2):167-173.
12. Łopuch S., Popik P. Cooperative behavior of laboratory rats (Rattus norvegicus) in a instrumental task. J Comp Psychol 2011, 125(2):250-253.
13. Wöhr M., Schwarting R.K.W. Ultrasonic communication in rats: can playback of 50-kHz calls induce approach behavior?. PloS One 2007, 2(12):e1365. 12 pp.
14. Wöhr M., Schwarting R.K. Ultrasonic communication in rats: effects of morphine and naloxone on vocal and behavioral responses to playback of 50-kHz vocalizations. Pharmacol Biochem Behav 2009, 94(2):285-295.
15. Sadananda M., Wöhr M., Schwarting R.K. Playback of 22-kHz and 50-kHz ultrasonic vocalizations induces differential c-fos expression in rat brain. Neurosci Lett 2008, 435(1):17-23.
16. Ahrens A.M., Ma S.T., Maier E.Y., Duvauchelle C.L., Schallert T. Repeated intravenous amphetamine exposure: rapid and persistent sensitization of 50-kHz ultrasonic trill calls in rats. Behav Brain Res 2009, 197(1):205-209.
17. Barker D.J., Root D.H., Ma S., Jha S., Megehee L., Pawlak A.P., et al. Dose-dependent differences in short ultrasonic vocalizations emitted by rats during cocaine self-administration. Psychopharmacology (Berl) 2010, 211(4):435-442.
18. Brudzynski S.M., Silkstone M., Komadoski M., Scullion K., Duffus S., Burgdorf J., et al. Effects of intraaccumbens amphetamine on production of 50kHz vocalizations in three lines of selectively bred Long-Evans rats. Behav Brain Res 2011, 217(1):32-40.
19. Burgdorf J., Knutson B., Panksepp J., Ikemoto S. Nucleus accumbens amphetamine microinjections unconditionally elicit 50-kHz ultrasonic vocalizations in rats. Behav Neurosci 2001, 115(4):940-944.
20. Ma S.T., Maier E.Y., Ahrens A.M., Schallert T., Duvauchelle C.L. Repeated intravenous cocaine experience: development and escalation of pre-drug anticipatory 50-kHz ultrasonic vocalizations in rats. Behav Brain Res 2010, 212(1):109-114.
21. Thompson B., Leonard K.C., Brudzynski S.M. Amphetamine-induced 50kHz calls from rat nucleus accumbens: a quantitative mapping study and acoustic analysis. Behav Brain Res 2006, 168(1):64-73.
22. Wright J.M., Gourdon J.C., Clarke P.B. Identification of multiple call categories within the rich repertoire of adult rat 50-kHz ultrasonic vocalizations: effects of amphetamine and social context. Psychopharmacology (Berl) 2010, 211(1):1-13.
23. Burgdorf J., Wood P.L., Kroes R.A., Moskal J.R., Panksepp J. Neurobiology of 50-kHz ultrasonic vocalizations in rats: electrode mapping, lesion, and pharmacology studies. Behav Brain Res 2007, 182(2):274-283.
24. Ciucci M.R., Ahrens A.M., Ma S.T., Kane J.R., Windham E.B., Woodlee M.T., et al. Reduction of dopamine synaptic activity: degradation of 50-kHz ultrasonic vocalization in rats. Behav Neurosci 2009, 123(2):328-336.
25. Seeman P., Van Tol H.H. Dopamine receptor pharmacology. Curr Opin Neurol Neurosurg 1993, 6(4):602-608.
26. Sibley D.R., Monsma F.J., Shen Y. Molecular neurobiology of dopaminergic receptors. Int Rev Neurobiol 1993, 35:391-415.
27. Perreault M.L., Hasbi A., Alijaniaram M., Fan T., Varghese G., Fletcher P.J., et al. The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia. J Biol Chem 2010, 285(47):36625-36634.
28. Lee S.P., So C.H., Rashid A.J., Varghese G., Cheng R., Lança A.J., et al. Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 2004, 279(34):35671-35678.
29. Maggio R., Millan M.J. Dopamine D2-D3 receptor heteromers: pharmacological properties and therapeutic significance. Curr Opin Pharmacol 2010, 10(1):100-107.
30. Marcellino D., Ferré S., Casadó V., Cortés A., Le Foll B., Mazzola C., et al. Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. J Biol Chem 2008, 283(38):26016-26025.
31. Maina F.K., Mathews T.A. A functional fast scan cyclic voltammetry assay to characterize dopamine D2 and D3 autoreceptors in the mouse striatum. ACS Chem Neurosci 2010, 1(6):450-462.
32. Pifl C., Drobny H., Reither H., Hornykiewicz O., Singer E.A. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol Pharmacol 1995, 47(2):368-373.
33. Mach R.H., Nader M.A., Ehrenkaufer R.L., Line S.W., Smith C.R., Gage H.D., et al. Use of positron emission tomography to study the dynamics of psychostimulant-induced dopamine release. Pharmacol Biochem Behav 1997, 57(3):477-486.
34. Sullivan R.M., Talangbayan H., Einat H., Szechtman H. Effects of quinpirole on central dopamine systems in sensitized and non-sensitized rats. Neuroscience 1998, 83(3):781-789.
35. Lindgren N., Usiello A., Goiny M., Haycock J., Erbs E., Greengard P., et al. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc Natl Acad Sci USA 2003, 100(7):4305-4309.
36. 3H]quinpirole. Eur J Pharmacol 1991, 203(1):105-109.
37. Seeman P., Van Tol H.H. Dopamine receptor pharmacology. Trends Pharmacol Sci 1994, 15(7):264-270.
38. Linthorst A.C., De Lang H., De Jong W., Versteeg D.H. Effect of the dopamine D2 receptor agonist quinpirole on the in vivo release of dopamine in the caudate nucleus of hypertensive rats. Eur J Pharmacol 1991, 201(2-3):125-133.
39. Svensson K., Carlsson A., Huff R.M., Kling-Petersen T., Waters N. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. Eur J Pharmacol 1994, 263(3):235-243.
40. Yamada S., Yokoo H., Nishi S. Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats. Brain Res 1994, 648(1):176-179.
41. St.Pierre J., Brudzynski S.M. D2 agonist quinpirole elicits 50kHz ultrasonic vocalizations from the nucleus accumbens in rats. Int Behav Neurosci Soc Abstr 2007, 16:78.
42. Komadoski M.D., Brudzynski S.M. Effects of low doses of quinpirole on production of 50kHz calls in rats. Int Behav Neurosci Abstr 2009, 18:62.
43. Brudzynski S.M. Ultrasonic vocalization induced by intracerebral carbachol in rats: localization and a dose-response study. Behav Brain Res 1994, 63:133-143.
44. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, Sydney. 2nd ed.
45. Paxinos G., Watson C., Pennisi M., Topple A. Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J Neurosci Methods 1985, 13(2):139-143.
46. 3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides. J Pharmacol Exp Ther 1995, 274(2):790-797.
47. Windle F.W., Rhines R., Rankin J. A Nissl method using buffered solution of thonin. Stain Technol 1943, 19(2):77-86.
48. Milliams S.N., Undieh A.S. Brain-derived neurotrophic factor signaling modulates cocaine induction of reward-associated ultrasonic vocalization in rats. J Pharm Exp Ther 2010, 332(2):463-468.
49. Jang J.Y., Jang M., Kim S.H., Um K.B., Kang Y.K., Kim H.J., et al. Regulation of dopaminergic neuron firing by heterogeneous dopamine autoreceptors in the substantia nigra pars compacta. J Neurochem 2011, 116(6):966-974.
50. Eilam D., Szechtman H. Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur J Pharmacol 1989, 161(2-3):151-157.
51. Neve K.A., Seamans J.K., Trantham-Davidson H. Dopamine receptor signalling. J Recept Signal Transduct 2004, 24:165-205.
52. 3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS Neurol Disord Drug Targets 2006, 5:25-43.
53. Xu M. Unraveling dopamine D3 receptor function in response to psychostimulants using a genetic approach. Ann N Y Acad Sci 1998, 844:27-39.
54. Diaz J., Lévesque D., Lammers C.H., Griffon N., Martres M.P., Schwartz J.C., Sokoloff P. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience 1995, 65(3):731-745.